This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Alberta directory, so their courses may be missing. Find their university profile.
Research
Latest papers
The association of angiostatin and plasminogen plasma levels with Charlson comorbidity burden and mortality in COVID-19.
Journal of thrombosis and thrombolysis · 2026 · senior author
Angiostatin-a novel SARS-CoV-2 inhibitor and biomarker underlying COVID-19 pathophysiology.
Journal of thrombosis and haemostasis : JTH · 2025 · senior author
Loading-Controlled Zymography.
Methods in molecular biology (Clifton, N.J.) · 2025 · senior author
Latest funding
- $623,475
Pharmacological Characterization of eNOS-based Platelet Subpopulations
CIHR · 2018 · Nominated PI
- $438,527
Characterization of Platelet Subpopulations based on the Heterogeneity of NOS Signaling: Significance for Hemostasis and Thrombosis
CIHR · 2013 · Nominated PI
- $100,000
Characterization of Platelet Subpopulations based on the Heterogeneity of NOS Signaling: Significance for Hemostasis and Thrombosis
CIHR · 2012 · Nominated PI
31 publications.
The association of angiostatin and plasminogen plasma levels with Charlson comorbidity burden and mortality in COVID-19.
Franczak A, Calistrate-Petre P, Dinu I, Jurasz P
Angiostatin-a novel SARS-CoV-2 inhibitor and biomarker underlying COVID-19 pathophysiology.
Franczak A, Joyce M, Lopez-Orozco J, Saffran HA, Saito M, Asgari A, Kalyaanamoorthy S, Barakat K, Hobman TC, Tyrrell DL, Jurasz P
Loading-Controlled Zymography.
Franczak A, Jurasz P
Elevated levels of pro-thrombotic eNOS-negative platelets in COVID-19 patients.
Asgari A, Franczak A, Herchen A, Jickling GC, Jurasz P
Role of Nitric Oxide in Megakaryocyte Function.
Asgari A, Jurasz P
Inhibition of platelet aggregation by activation of platelet intermediate conductance Ca2+ -activated potassium channels.
Back V, Asgari A, Franczak A, Saito M, Castaneda Zaragoza D, Sandow SL, Plane F, Jurasz P
Editorial: Established and Novel Roles of Platelets in Health and Disease.
Jurasz P, Ignjatovic V, Lordkipanidzé M
Platelets stimulate programmed death-ligand 1 expression by cancer cells: Inhibition by anti-platelet drugs.
Asgari A, Lesyk G, Poitras E, Govindasamy N, Terry K, To R, Back V, Rudzinski JK, Lewis JD, Jurasz P
Preferential interaction of platelets with prostate cancer cells with stem cell markers.
Rudzinski JK, Govindasamy NP, Asgari A, Saito MS, Lewis JD, Jurasz P
L-Arginine and NOS activity, a complex relationship.
Le Melledo JM, Baker G, Gyenes G, Tsuyuki R, Jurasz P
Pharmacological Characterization of eNOS-based Platelet Subpopulations
Principal investigators: Jurasz, Paul K
Keywords: Anti-Platelet Drugs; Endothelial Nitric Oxide Synthase; Flow Cytometry; Matrix Metalloproteinases; Myocardial Infarction; Nitric Oxide; Pharmacology; Platelet Function Testing; Platelets; Prognostic Biomarkers
Characterization of Platelet Subpopulations based on the Heterogeneity of NOS Signaling: Significance for Hemostasis and Thrombosis
Principal investigators: Jurasz, Paul K
Keywords: Aggregometry; Endothelial Nitric Oxide Synthase; Flow Cytometry; Fluorescence Activated Cell Sorting; Fluorescence Microscopy; Nitric Oxide; Platelet Pharmacology; Platelet Subpopulations; Quartz Crystal Microbalance Flow Assay; Stroke Patients
Characterization of Platelet Subpopulations based on the Heterogeneity of NOS Signaling: Significance for Hemostasis and Thrombosis
Principal investigators: Jurasz, Paul K
Keywords: Aggregometry; Endothelial Nitric Oxide Synthase; Flow Cytometry; Fluorescence Activated Cell Sorting; Fluorescence Microscopy; Nitric Oxide; Platelet Pharmacology; Platelet Subpopulations; Quartz Crystal Microbalance Flow Assay; Stroke Patients
Role of Platelets in Angiogenesis: Selective PKC Inhibition Uncouples Platelet Hemostasis from Angiogenesis Promotion
Principal investigators: Jurasz, Paul K
Keywords: Aggregometry; Alpha-Granules; Angiogenesis; Flow Cytometry; Platelets; Protein Kinase C
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Pharmacy and Pharmaceutical Sciences
- Medicine/Cardiology
- Oncology
- Medicine/Nephrology
- Other
Co-authors at University of Alberta, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
John Seubert
Faculty
2 shared papers, latest 2017
Ayman El-Kadi
Pharmacy and Pharmaceutical Sciences
1 shared papers, latest 2017
Richard Fahlman
Faculty
1 shared papers, latest 2015
Khaled Barakat
Faculty
1 shared papers, latest 2025
Arno Siraki
Faculty
1 shared papers, latest 2017
Ross Tsuyuki
Medicine/Nephrology
1 shared papers, latest 2021
Roseline Godbout
Oncology
1 shared papers, latest 2017
Afsaneh Lavasanifar
Faculty
1 shared papers, latest 2017
Evangelos Michelakis
Medicine/Cardiology
1 shared papers, latest 2013
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.